Diabetes Drug Recalled Due to High Levels of Substance that ‘Could Cause Cancer,’ FDA Says
Marksans Pharma Limited had expanded its voluntary recall of Metformin Hydrochloride Extended-Release Tablets
A drug commonly used to treat Type 2 diabetes has been recalled due to cancer concerns.
This week, the Food and Drug Administration announced that Marksans Pharma Limited had expanded its voluntary recall of Metformin Hydrochloride Extended-Release Tablets. An additional 76 unexpired lots were determined to possibly contain levels of NDMA — which is classified by the FDA as a “probable human carcinogen (a substance that could cause cancer)” — that exceed acceptable daily amounts.